Cafepharma Today

September 25 2024 - Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Sanofi reportedly gets PE bids for consumer health unit
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Max Colao Shares How OncoVerity is Pioneering Oncology Solutions
pharmexec
Drug Channels News Roundup, September 2024: Inside JNJ’s Gross-to-Net Bubble, Optum Rx’s Private Label Biosimilars, Where Biosimilars Boom, Accumulators vs. Patients, and Steve Collis Retires
Drug Channels
Pharma Pulse 9/24/24: The Financial Benefits of Technology, Empathy Left Outside the Exam Room Door & more
pharmexec
The Impact of FDA’s Guidance on Mammography Quality Standards Act: Q&A with Steven C. Quay
pharmexec
What is a Mega Campus?
pharmexec
FDA Approves Sarclisa for Certain Patients with Multiple Myeloma
pharmexec
FDA Approves Bimzelx for Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
pharmexec
Stealing Protein Degrader Secrets?
In the Pipeline
Informa Connnect's Pharma/Biotech GTN Summit
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Los Angeles East, CA
Los Angeles, California,
Otsuka
Pharmaceutical Sales Customer Engagement- Gainesville, FL
Gainesville, Florida,
Otsuka
Psychiatry Account Manager - Boise, ID
Boise, Idaho, US
Lundbeck
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania,
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Portland N, OR
Portland, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Zanesville-Portsmouth
Ohio, Ohio,
Otsuka
Pharmaceutical Sales Customer Engagement - Bangor, ME
Bangor, Maine,
Otsuka
Pharmaceutical Sales Customer Engagement - Danville-Reading
Reading, Pennsylvania,
Otsuka
Pharmaceutical Sales Customer Engagement - Springfield E, MO
Springfield, Missouri,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information